Author

N. Monakhova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

O. Riabova· 2 shared V. Makarov· 2 shared A. C. Puhl· 1 shared A. M. Nakamura· 1 shared A. S. de Godoy· 1 shared A. T. Fabro· 1 shared B. Gap-Gaupool· 1 shared B. Stewart· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

O. Riabova

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pyronaridine Protects Against SARS-CoV-2 in Mouse

A. C. Puhl, G. F. Gomes, S. Damasceno, A. S. de Godoy, G. D. Noske, A. M. Nakamura, V. O. Gawrijuk, R. S. Fernandes, N. Monakhova, O. Riabova, T. R. Lane, V. Makarov, F. P. Veras, S. S. Batah, A. T. Fabro, , S. Ekins

Pyronaridine reduces SARS-CoV-2 viral load and lung pathology in mice, with in vitro inhibition of viral PLpro and host kinase CAMK1.

bioRxiv · Sep 30, 2021 · PreprintPharmacology & Toxicology

Exposure to nitric oxide drives transition to differential culturability in Mycobacterium tuberculosis

S. M. Glenn, B. Gap-Gaupool, E. Milburn, O. Turapov, M. Crosatti, J. Hincks, B. Stewart, J. Bacon, S. L. Kendall, M. I. Voskuil, O. Riabova, N. Monakhova, J. Green, S. J. Waddell, V. Makarov, G. V. Mukamolova

This study shows that nitric oxide exposure leads to the formation of Rpf-dependent differentially culturable Mycobacterium tuberculosis subpopulations, which are resistant to standard diagnostics and treatments.

bioRxiv · Sep 28, 2021 · PreprintMicrobiology